Detalles de la búsqueda
1.
Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study.
Alzheimers Dement
; 20(4): 2766-2778, 2024 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-38425134
2.
Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.
Alzheimers Dement
; 18(11): 2199-2208, 2022 11.
Artículo
Inglés
| MEDLINE | ID: mdl-35103400
3.
Diagnostic criteria for apathy in neurocognitive disorders.
Alzheimers Dement
; 17(12): 1892-1904, 2021 12.
Artículo
Inglés
| MEDLINE | ID: mdl-33949763
4.
Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation.
J Geriatr Psychiatry Neurol
; 33(4): 175-184, 2020 07.
Artículo
Inglés
| MEDLINE | ID: mdl-31547752
5.
Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-analysis.
Can J Psychiatry
; 65(12): 821-834, 2020 12.
Artículo
Inglés
| MEDLINE | ID: mdl-32148076
6.
The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment.
Am J Geriatr Psychiatry
; 27(8): 873-882, 2019 08.
Artículo
Inglés
| MEDLINE | ID: mdl-30910421
7.
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
Am J Geriatr Psychiatry
; 27(11): 1161-1173, 2019 11.
Artículo
Inglés
| MEDLINE | ID: mdl-31182351
8.
Pharmacological interventions for apathy in Alzheimer's disease.
Cochrane Database Syst Rev
; 5: CD012197, 2018 May 04.
Artículo
Inglés
| MEDLINE | ID: mdl-29727467
9.
Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
Alzheimers Dement
; 14(10): 1344-1376, 2018 10.
Artículo
Inglés
| MEDLINE | ID: mdl-29940162
10.
Latrepirdine for Alzheimer's disease.
Cochrane Database Syst Rev
; (4): CD009524, 2015 Apr 21.
Artículo
Inglés
| MEDLINE | ID: mdl-25897825
11.
Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach.
J Am Heart Assoc
; 12(1): e025724, 2023 01 03.
Artículo
Inglés
| MEDLINE | ID: mdl-36565204
12.
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
JAMA Neurol
; 80(12): 1353-1363, 2023 Dec 01.
Artículo
Inglés
| MEDLINE | ID: mdl-37843849
13.
Agitation and impulsivity in mid and late life as possible risk markers for incident dementia.
Alzheimers Dement (N Y)
; 6(1): e12016, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-32995467
14.
Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis.
J Clin Psychiatry
; 80(2)2019 01 29.
Artículo
Inglés
| MEDLINE | ID: mdl-30753761
15.
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone.
J Alzheimers Dis
; 71(1): 21-31, 2019.
Artículo
Inglés
| MEDLINE | ID: mdl-31322567
16.
Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial.
Contemp Clin Trials Commun
; 15: 100385, 2019 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-31338476
17.
Psychometric properties of apathy scales in Parkinson's disease: a systematic review.
Neurodegener Dis Manag
; 8(4): 267-282, 2018 08.
Artículo
Inglés
| MEDLINE | ID: mdl-30040024
18.
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia.
Curr Opin Psychiatry
; 31(2): 140-146, 2018 03.
Artículo
Inglés
| MEDLINE | ID: mdl-29256923
19.
Psychometric Properties of Apathy Scales in Dementia: A Systematic Review.
J Alzheimers Dis
; 66(3): 1065-1082, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-30400094
20.
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Expert Opin Pharmacother
; 17(18): 2417-2429, 2016 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-27825018